You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

URSO FORTE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Urso Forte, and what generic alternatives are available?

Urso Forte is a drug marketed by Allergan and is included in one NDA.

The generic ingredient in URSO FORTE is ursodiol. There are eight drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the ursodiol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Urso Forte

A generic version of URSO FORTE was approved as ursodiol by EPIC PHARMA on March 14th, 2000.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for URSO FORTE?
  • What are the global sales for URSO FORTE?
  • What is Average Wholesale Price for URSO FORTE?
Drug patent expirations by year for URSO FORTE
Drug Prices for URSO FORTE

See drug prices for URSO FORTE

Pharmacology for URSO FORTE
Drug ClassBile Acid

US Patents and Regulatory Information for URSO FORTE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan URSO FORTE ursodiol TABLET;ORAL 020675-002 Jul 21, 2004 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for URSO FORTE

See the table below for patents covering URSO FORTE around the world.

Country Patent Number Title Estimated Expiration
France 2607005 COMPOSITIONS PHARMACEUTIQUES CONTENANT DE L'ACIDE URSODESOXYCHOLIQUE ⤷  Subscribe
Canada 1318590 COMPOSITIONS PHARMACEUTIQUES CONTENANT DE L'ACIDE URSODESOXYCHOLIQUE (PHARMACEUTICAL COMPOSITIONS CONTAINING URSODEOXYCHOLIC ACID) ⤷  Subscribe
Japan S63141929 MEDICINAL COMPOSITION CONTAINING ULSODEOXYCHOLIC ACID ⤷  Subscribe
European Patent Office 0269516 ⤷  Subscribe
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.